NCT00782730
Completed
Not Applicable
Assessment of Third Trimester Post-void Residual Along With Determining Validity of the Bladder Scanner in the Third Trimester of Pregnancy and Postpartum
ConditionsPregnancy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pregnancy
- Sponsor
- West Virginia University
- Enrollment
- 35
- Locations
- 1
- Primary Endpoint
- Define normal post-void residual volume in third trimester pregnancy and post-partum.
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
This will be a descriptive study measuring the post-void residual of patients in the third trimester and postpartum. Also, bladder scan values will be compared to the amount of urine obtained from a Foley catheter to determine the accuracy of the bladder scanner in the third trimester and postpartum.
Investigators
Michael Stitely
Adjunct Associate Professor
West Virginia University
Eligibility Criteria
Inclusion Criteria
- •Age greater than 18 years.
- •Having a non-emergent Cesarean Delivery or labor epidural placed.
Exclusion Criteria
- •Age less than 18 years.
- •Emergent Cesarean delivery.
- •No epidural labor analgesia.
Outcomes
Primary Outcomes
Define normal post-void residual volume in third trimester pregnancy and post-partum.
Time Frame: 12-24 hours
Secondary Outcomes
- Calculate the validity of measurements form the bladder scanner ultrasound for bladder volumes during the third trimester of pregnancy and post-partum.(12-24 hours)
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
Normal and Pathological Values of Postvoiding Residual Volume in Early Postpartum Period and Their Predisposing FactorsUrinary RetentionNCT03958279Comenius University930
Not yet recruiting
Not Applicable
Examination of Pregnant Women in Third Trimester by Ultrasound to Detect Any Congenital AnomaliesCongenital AnomalyNCT06628063Sohag University40
Completed
Not Applicable
Third Trimester Modified Biophysical Profile Scan for Predicting Fetal Outcome.Perinatal DeathThird Trimester Modified Biophysical Profile ScanNCT03729089Dr Andrew Odur198
Completed
Not Applicable
Evaluation of fetotoxicity after 2nd and 3rd trimester exposure to NSAID, metamizole, acetylsalicylic acid and paracetamolMedDRA - 10049996 Ductus arteriosus premature closure MedDRA - 10013808 Ductus arteriosus stenosis foetalMedDRA - 10034130 Patent ductus arteriosus (PT, 21.1)MedDRA - 10030289 OligohydramniosMedDRA - 10066470 Amniorrhoea MedDRA - 10042062 StillbirthMedDRA - 10055690 Fetal deathMedDRA - 10050701 Congenital pulmonary hypertensionMedDRA - 10038447 Renal failure neonatalMedDRA - 10049778 Neonatal anuria MedDRA - 10030302 OliguriaDRKS00015617Pharmakovigilanzzentrum Embryonaltoxikologie, Charité Universitätsmedizin Berlin4,000
Completed
Phase 3
Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine, When Administered to Adults Affected by Chronic DiseasesInfluenza DiseaseNCT00519064Novartis Vaccines361